Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
26 Jun, 2017 | 17:20h | UTCEfficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older – New England Journal of Medicine (link to abstract – $ for full-text)
“Say bye to egg-grown flu vaccine? Recombinant vaccines are a little more effective & much quicker to adapt” (RT @RichardLehman1 see Tweet and brief commentaries on the study)